Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes.
Qin
Xuebin
X
Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Goldfine
Allison
A
Krumrei
Nicole
N
Grubissich
Luciano
L
Acosta
Juan
J
Chorev
Michael
M
Hays
Arthur P
AP
Halperin
Jose A
JA
D000368:Aged; D000918:Antibody Specificity; D015703:Antigens, CD / Q000276:immunology; D018957:CD59 Antigens / Q000276:immunology*; D015938:Complement Membrane Attack Complex / Q000276:immunology; D003404:Creatinine / Q000097:blood; D003920:Diabetes Mellitus / Q000503:physiopathology*; D003925:Diabetic Angiopathies / Q000503:physiopathology*; D003928:Diabetic Nephropathies / Q000276:immunology; D005260:Female; D006031:Glycosylation; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011507:Proteinuria; D011994:Recombinant Proteins / Q000276:immunology
D015703:Antigens, CD; D018957:CD59 Antigens; D015938:Complement Membrane Attack Complex; D011994:Recombinant Proteins; D003404:Creatinine